Healionics Overview

  • Founded
  • 2007
Founded
  • Status
  • Private
  • Employees
  • 11
Employees
  • Latest Deal Type
  • Debt - PPP
  • Investors
  • 14

Healionics General Information

Description

Developer of synthetic biomaterial-based vascular graft designed to improve the dialysis access in patients with kidney failure. The company's vascular graft resists the problems of occlusion and infection suffered by current devices, enabling medical practitioners to treat the kidney patients who undergo dialysis treatment in a better and safe manner.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Diagnostic Equipment
Primary Office
  • 2121 North 35th Street
  • Suite 200
  • Seattle, WA 98103
  • United States
+1 (206) 000-0000

Healionics Timeline

2017201820192020
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Healionics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Debt - PPP 27-Apr-2020 000.00 Completed Generating Revenue
12. Later Stage VC 31-Jul-2019 00.00 000.00 Completed Generating Revenue
11. Later Stage VC 01-May-2019 0000 00.000 Completed Generating Revenue
10. Later Stage VC 01-Dec-2018 00.000 00.000 Completed Generating Revenue
9. Grant 16-Nov-2017 00.00 00.000 Completed Generating Revenue
8. Grant 01-Dec-2015 00.00 00.000 Completed Generating Revenue
7. Grant 08-Sep-2014 00000 00.000 Completed Generating Revenue
6. Grant 20-Sep-2012 00000 00.000 Completed Startup
5. Later Stage VC (Series C) 06-May-2011 $343K $4.64M 00.000 Completed Startup
4. Grant 12-Nov-2010 $444K $4.3M Completed Startup
To view Healionics’s complete valuation and funding history, request access »

Healionics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series B 000,000 00.000000 00.00 000.00 000.00 00 000.00 00.000
Series A 300,000 $0.001000 $0.47 $5.91 $5.91 1x $5.91 20.07%
To view Healionics’s complete cap table history, request access »

Healionics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of synthetic biomaterial-based vascular graft designed to improve the dialysis access in patients with kidney
Therapeutic Devices
Seattle, WA
11 As of 2020
000.00
000000000 - 000.00

00000

et, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
00000000000 0000000
Redwood City, CA
000 As of 0000
00000
00000000000 00000

0000000

exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repr
00000000000 0000000
Norwalk, CT
00 As of 0000
00.00
000000000 - 00.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Healionics Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nevro Formerly VC-backed Redwood City, CA 000 00000 00000000000 00000
0000000 Venture Capital-Backed Norwalk, CT 00 00.00 000000000 - 00.00
0000 Venture Capital-Backed Minneapolis, MN 00 00000 00000000000 00000
000000000 Corporation Minneapolis, MN 00000 00000000
0000000 Corporation Lancashire, United Kingdom
You’re viewing 5 of 9 competitors. Get the full list »

Healionics Executive Team (3)

Name Title Board Seat Contact Info
Michael Connolly Chief Executive Officer & Chairman
Max Maginness Ph.D President & Chief Operating Officer
Andrew Marshall Ph.D Board Member & Chief Technology Officer
To view Healionics’s complete executive team members history, request access »

Healionics Board Members (6)

Name Representing Role Since
Andrew Marshall Ph.D Healionics Board Member & Chief Technology Officer 000 0000
Arthur Coury Ph.D Self Board Member & Scientific Advisor 000 0000
Buddy Ratner Ph.D Self Scientific Advisor & Board Member 000 0000
Michael Connolly Healionics Chief Executive Officer & Chairman 000 0000
Ryan Takeuchi Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Healionics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Healionics Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Arizona Tech Investors Angel Group Minority 000 0000 000000 0
iSelect Fund Venture Capital Minority 000 0000 000000 0
Mid Atlantic Bio Angels Angel Group 000 0000 000000 0
Rockies Venture Club Angel Group Minority 000 0000 000000 0
Tech Coast Angels Angel Group Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »

Healionics Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000000 14-Oct-2014 00000 00000 00 00.000 Surgical Devices 000 000000000 00.0
To view Healionics’s complete investments history, request access »